UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018444
Receipt number R000021192
Scientific Title Anxiety and depression in patients with retinitis pigmentosa
Date of disclosure of the study information 2015/08/01
Last modified on 2020/01/29 14:45:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Anxiety and depression in patients with retinitis pigmentosa

Acronym

Anxiety and depression in RP patients

Scientific Title

Anxiety and depression in patients with retinitis pigmentosa

Scientific Title:Acronym

Anxiety and depression in RP patients

Region

Japan


Condition

Condition

Retinitis pigmentosa
Healthy volunteer

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the anxiety state and the depressive state in patients with retinitis pigmentosa

Basic objectives2

Others

Basic objectives -Others

To investigate the anxiety state and the depressive state between patients with retinitis pigmentosa and healthy volunteers

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

The anxiety and the depression using the Hospital Anxiety and Depression Sale(HADS)

Key secondary outcomes

NEI VFQ-25,visual impairment,severe disease,
marital status,bereavement experience, social support,visual rehabilitation,JRPS,
assessment for visual functions including measurements of visual acuity, vusual field


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.outpatients with retinitis pigmentosa
2.patients whose agreement was shown

Healthy volunteers
no ocular diseases


Key exclusion criteria

All participants who had a history of psychiatric treatment and psychotropic drug use were excluded

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Taiji
Middle name
Last name Sakamoto

Organization

Kagoshima University Hospital

Division name

Department of Ophthalmology

Zip code

8908520

Address

8-35-1, Sakuragaoka,Kagoshima-city,Kagoshima,Japan

TEL

099-275-5402

Email

sai.kagoshima.u@gmail.com


Public contact

Name of contact person

1st name Takehiro
Middle name
Last name Yamashita

Organization

Kagoshima University

Division name

Department of Ophthalmology

Zip code

8908520

Address

8-35-1, Sakuragaoka,Kagoshima-city,Kagoshima,Japan

TEL

099-275-5402

Homepage URL


Email

sai.kagoshima.u@gmail.com


Sponsor or person

Institute

Kagoshima University

Institute

Department

Personal name



Funding Source

Organization

Kagoshima University
Department of Ophthalmolpgy

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kagoshima University Department of Ophthalmolpgy

Address

8-35-1, Sakuragaoka,Kagoshima-city,Kagoshima,Japan

Tel

099-275-5111

Email

isgskkrs@kuas.kagoshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 01 Day


Related information

URL releasing protocol

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912752/

Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912752/

Number of participants that the trial has enrolled

112

Results

The hads-A score was not significantly correlated with any visual functions but was significantly correlated with the general health condition (r = -0.34, P<0.001) and the role limitation (r = -0.20, P = 0.03) of the nei vfq25subscale

Results date posted

2020 Year 01 Month 29 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

112 rp patients

Participant flow

All of the patients were consecutively asked to participant in this study at Kagoshima University Hospital, Miyata Eye Hospital, Kofu Kyoritsu Hospital, Osaka University Hospital, and Kyushu University Hospital during August 2015 to February 2017.

Adverse events

none

Outcome measures

the hads and the nei-vfq25 questionnaires.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 07 Month 24 Day

Date of IRB

2016 Year 06 Month 07 Day

Anticipated trial start date

2016 Year 06 Month 07 Day

Last follow-up date

2018 Year 01 Month 31 Day

Date of closure to data entry

2018 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

prospective, case-control study


Management information

Registered date

2015 Year 07 Month 27 Day

Last modified on

2020 Year 01 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021192


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name